These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 10064252

  • 1. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group.
    Rotstein C, Bow EJ, Laverdiere M, Ioannou S, Carr D, Moghaddam N.
    Clin Infect Dis; 1999 Feb; 28(2):331-40. PubMed ID: 10064252
    [Abstract] [Full Text] [Related]

  • 2. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W.
    Cancer; 1998 Jul 15; 83(2):291-301. PubMed ID: 9669812
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP, Kurup A, Goh YT, Fook-Chong SM, Tan PH.
    Am J Hematol; 2002 Dec 15; 71(4):260-7. PubMed ID: 12447954
    [Abstract] [Full Text] [Related]

  • 4. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN, Estey E, Raad I, Giles F, Cortes J, Shen Y, Kontoyiannis D, Koller C, Munsell M, Beran M, Kantarjian H.
    Cancer; 2003 Jan 15; 97(2):450-6. PubMed ID: 12518369
    [Abstract] [Full Text] [Related]

  • 5. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ, Laverdière M, Lussier N, Rotstein C, Cheang MS, Ioannou S.
    Cancer; 2002 Jun 15; 94(12):3230-46. PubMed ID: 12115356
    [Abstract] [Full Text] [Related]

  • 6. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany.
    J Antimicrob Chemother; 2006 Feb 15; 57(2):317-25. PubMed ID: 16339606
    [Abstract] [Full Text] [Related]

  • 7. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
    Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ.
    N Engl J Med; 1992 Mar 26; 326(13):845-51. PubMed ID: 1542320
    [Abstract] [Full Text] [Related]

  • 8. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D.
    N Engl J Med; 2007 Jan 25; 356(4):348-59. PubMed ID: 17251531
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
    Kanda Y, Yamamoto R, Chizuka A, Hamaki T, Suguro M, Arai C, Matsuyama T, Takezako N, Miwa A, Kern W, Kami M, Akiyama H, Hirai H, Togawa A.
    Cancer; 2000 Oct 01; 89(7):1611-25. PubMed ID: 11013378
    [Abstract] [Full Text] [Related]

  • 10. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ, Böhme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA.
    J Infect; 2007 Nov 01; 55(5):445-9. PubMed ID: 17822770
    [Abstract] [Full Text] [Related]

  • 11. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.
    Bone Marrow Transplant; 2006 Jul 01; 38(2):127-34. PubMed ID: 16751782
    [Abstract] [Full Text] [Related]

  • 12. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.
    van Burik JA, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH, Bunin N, Wall DA, Hiemenz JW, Satoi Y, Lee JM, Walsh TJ, National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Clin Infect Dis; 2004 Nov 15; 39(10):1407-16. PubMed ID: 15546073
    [Abstract] [Full Text] [Related]

  • 13. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
    Kelsey SM, Goldman JM, McCann S, Newland AC, Scarffe JH, Oppenheim BA, Mufti GJ.
    Bone Marrow Transplant; 1999 Jan 15; 23(2):163-8. PubMed ID: 10197802
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
    Schonfeld W, Wang Cheng J, Tong KB, Seifeldin R.
    Clin Ther; 2008 May 15; 30(5):964-73. PubMed ID: 18555943
    [Abstract] [Full Text] [Related]

  • 15. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
    Riedel A, Choe L, Inciardi J, Yuen C, Martin T, Guglielmo BJ.
    BMC Infect Dis; 2007 Jul 02; 7():70. PubMed ID: 17605773
    [Abstract] [Full Text] [Related]

  • 16. Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
    Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG.
    N Engl J Med; 2001 Dec 06; 345(23):1660-6. PubMed ID: 11759644
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
    Nucci M, Biasoli I, Akiti T, Silveira F, Solza C, Barreiros G, Spector N, Derossi A, Pulcheri W.
    Clin Infect Dis; 2000 Feb 06; 30(2):300-5. PubMed ID: 10671332
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS, Lee TJ, Kim J, Kim D.
    Clin Ther; 2009 May 06; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [Abstract] [Full Text] [Related]

  • 19. How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia.
    Menichetti F.
    Clin Infect Dis; 2004 Oct 15; 39 Suppl 4():S181-4. PubMed ID: 15546115
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Sharpe MD, Ghent C, Grant D, Horbay GL, McDougal J, David Colby W.
    Transplantation; 2003 Sep 27; 76(6):977-83. PubMed ID: 14508365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.